Nattokinase Supplementation and Hemostatic Factors
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02913170
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02913170
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02913170. Randomized; triple masking; primary purpose supportive care. Start 2015-05 (registry gives no type); primary completion 2016-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nattokinase Supplementation and Hemostatic Factors
- Condition
- Hypercholesterolemia
- Intervention (Dietary supplement)
- Nattokinase
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02913170- Content hash
4eaef5d6f94aaf0337456288d6bdcbe34cbb1e382467d79173a4874c9525e9ea